The largest database of trusted experimental protocols

7 protocols using anti cd226

1

Comprehensive Phenotyping of Human CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly obtained peripheral blood mononuclear cell (PBMC) were stained with anti-CD4 (-FITC from Biolegend, OKT4, USA), anti-CD25 (-PE from Biolegend, BC96, USA), anti-CD127 (-PECY7 from Biolegend, A019D5, USA), anti-CD226 (-APC from Biolegend, 11A8, USA), anti-TIGIT (-APC from eBioscience, MBSA43, USA). Intracellular detection of Foxp3 with anti-Foxp3 (-Percp-Cy5.5 from eBioscience, 236A/E7, USA) and Helios with anti-Helios (-APC from Biolegend, 22F6, USA) was performed on fixed and permeabilized cells via Foxp3 Staining Buffer Set (eBioscience, USA). Cell fluorescence was acquired on BD LSR Fortessa (BD Biosciences, USA) and analyzed with FlowJo software (version 7.6.5; Tree Star). We usually acquired 10, 000 events in FSC. CD4-FITC positive and SSC gates were used to delineate CD4+ cells, then gated with CD25-PE and CD127-PECY7 in these cells, and the acquisition gate was designed on the CD4+CD25highCD127low/− cells.
+ Open protocol
+ Expand
2

Comprehensive Phenotyping of Human CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly obtained peripheral blood mononuclear cell (PBMC) were stained with anti-CD4 (-FITC from Biolegend, OKT4, USA), anti-CD25 (-PE from Biolegend, BC96, USA), anti-CD127 (-PECY7 from Biolegend, A019D5, USA), anti-CD226 (-APC from Biolegend, 11A8, USA), anti-TIGIT (-APC from eBioscience, MBSA43, USA). Intracellular detection of Foxp3 with anti-Foxp3 (-Percp-Cy5.5 from eBioscience, 236A/E7, USA) and Helios with anti-Helios (-APC from Biolegend, 22F6, USA) was performed on fixed and permeabilized cells via Foxp3 Staining Buffer Set (eBioscience, USA). Cell fluorescence was acquired on BD LSR Fortessa (BD Biosciences, USA) and analyzed with FlowJo software (version 7.6.5; Tree Star). We usually acquired 10, 000 events in FSC. CD4-FITC positive and SSC gates were used to delineate CD4+ cells, then gated with CD25-PE and CD127-PECY7 in these cells, and the acquisition gate was designed on the CD4+CD25highCD127low/− cells.
+ Open protocol
+ Expand
3

Immunophenotyping and T Cell Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
ASTRLs and PBMCs were immunophenotyped for various cell surface markers by flow cytometry with fluorophore conjugated human anti-CD3, anti-CD4, anti-CD8, anti-CD25, anti-CD127, anti-CD39 and anti-CD73 anti-CTLA4, anti-GITR, anti-ICOS, anti-CD45RA, anti-CD226, anti-LAP, anti-GARP, anti-CD56, anti-CD16, anti-CD19, anti-CD11b, anti-CD38, anti-CD27, and anti-CD24 (Biolegend). The data were acquired using a Canto II cytometer (BD Biosciences) and analyzed using Flowjo. The gating strategy for phenotyping included initial gating of a live PBMC population followed by the CD3+CD4+ population. The expression of CD25, CD127, CD39, and CD73 were expressed as % of the CD3+CD4+ population.
T cell proliferation and suppression was determined by CFSE dye dilution of the responder cells. Analysis of CFSE distribution was performed on Flowjo Proliferation platform and data are represented by Replication Index (RI). RI, determines the fold-expansion of only the responding cells, and it is the average number of divisions that all cells have undergone after they had been stained by a cell proliferation dye (13 (link)). The percentage of suppression was calculated from proliferation and suppression values.
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For multiparametric flow cytometry analysis, PBMC were stained and enriched with the matched MHC class I or class II tetramer. To exclude dead cells in the subsequent analysis, PBMC were stained with the LIVE/DEAD™ Fixable Near-IR dye (Thermo Fisher, Germany) according to the manufacturer’s protocol. PBMC were stained with appropriate fluorochrome-conjugated surface antibodies, including anti-CD3 (OKT3), anti-CD4 (RPA-T4) anti-CD45RO (UCHL1), anti-CCR7 (G043H7), anti-CD226 (DX11), anti-TIGIT (A15153G), anti-BTLA (MIH26), anti-LIGHT (115520), anti-Ceacam1 (ASL-32), anti-Tim-3 (F38-2E2), anti-PD-1 (EH12.2H7), anti-OX40 (ACT-35), anti-CD14 (63D3), anti-CD19 (HIB19) (from Biolegend, Koblenz or BD Biosciences, Heidelberg, Germany) for 20 min at RT in the dark. After surface staining, cells were washed once with PBS and were then resuspended in 0.5% paraformaldehyde.
+ Open protocol
+ Expand
5

NK Cell-Mediated Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
NK cells were stimulated at indicated time points with HNSCC targets for 6 hours in presence of 1 ng/mL rhIL15. Effector to target (E:T) ratio was 5:1, unless otherwise indicated, with anti-CD107a antibody (Biolegend; RRID:AB_1227509) for 6 hours, with Golgi Plug/Stop present in the last 5 hours. When indicated, NK cells were pre-incubated, IgG1 Isotype control (5μg/mL; BioLegend; RRID:AB_2801451), anti-NKG2D (5μg /mL; BioLegend; RRID:AB_2810480), anti-CD2 (5 μg/mL; BD-Biosciences; RRID:AB_395731) or anti-CD226 (5μg/mL; BioLegend; RRID:AB_1279155) blocking antibodies 30 minutes before incubation with tumor targets. In Cetuximab experiments, tumor cells were pre-incubated with anti-EGFR antibody cetuximab (10μg/mL; Lily) prior to incubation with NK cells. Cells were stained for flow cytometry analysis as described previously.19 Degranulation (CD107a), TNF and IFN-γ were assessed by flow cytometry.16 (link),20 (link),26 (link) Data were acquired on a Gallios flow cytometer (Beckman Coulter) and analyzed using FlowJo software (Tree Star v10.6; RRID:SCR_008520).
+ Open protocol
+ Expand
6

NK Cell Activation Assays and Immune Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
NK cell activation assays were performed with PBMCs at a PBMC to target cell ratio of 5:1. PBMCs yielded 10% NK cells on average. Functional studies were performed in the presence and absence of blocking antibodies to NKG2D, CD226 or CD96 on NK cells and MICA, MICB, CD155, CD112 tumour cell surfaces respectively. Here, cells were incubated in 1ug/mL solutions of either anti-NKG2D (R&D clone# 149810), anti-MICA (R&D clone# 159227), anti-MICB (R&D clone# 236511), anti-CD226 (BioLegend clone# 11A8), anti-CD96 (BioLegend clone# 92.39), anti-CD155 (BioLegend clone# SKII.4) and anti-CD112 (BioLegend clone# TX.31) for 1 hour at room temperature and washed to remove excess soluble antibody. Recombinant MICA and MICB were used at a final concentration of 10μg/mL for 30 minutes with PBMCs. IgG controls were used for each experiment.
Recombinant TGFbeta was used to pre-treat PBMCs for 1 hour at room temperature prior to functional assay in relevant experiments.
Activated platelets were obtained by incubating washed platelets with 125μg/mL thrombin receptor-activated peptide (TRAP) for 30 minutes at room temperature under gentle rocking conditions. Activated platelets, and their releasate, were then used in functional assays as indicated within the text.
+ Open protocol
+ Expand
7

NK Cell Cytotoxicity Assay with HNSCC Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
NK cells were stimulated at indicated time points with HNSCC targets for 6 hours in presence of 1 ng/mL rhIL15. Effector to target (E:T) ratio was 5:1, unless otherwise indicated, with anti-CD107a antibody (Biolegend; RRID:AB_1227509) for 6 hours, with Golgi Plug/Stop present in the last 5 hours. When indicated, NK cells were pre-incubated, IgG1 Isotype control (5μg/mL; BioLegend; RRID:AB_2801451), anti-NKG2D (5μg /mL; BioLegend; RRID:AB_2810480), anti-CD2 (5 μg/mL; BD-Biosciences; RRID:AB_395731) or anti-CD226 (5μg/mL; BioLegend; RRID:AB_1279155) blocking antibodies 30 minutes before incubation with tumor targets. In Cetuximab experiments, tumor cells were pre-incubated with anti-EGFR antibody cetuximab (10μg/mL; Lily) prior to incubation with NK cells. Cells were stained for flow cytometry analysis as described previously. 19 Degranulation (CD107a), TNF and IFN-γ were assessed by flow cytometry. 16, 20, 26 Data were acquired on a Gallios flow cytometer (Beckman Coulter) and analyzed using FlowJo software (Tree Star v10.6; RRID:SCR_008520).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!